|
FBLG Fibrobiologics Inc 1958777 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-5,000,000.00 |
| Balance Sheet |
|
Current Assets
|
$2,905,000.00 |
|
Assets
|
$5,938,000.00 |
|
Current Liabilities
|
$1,829,000.00 |
|
Liabilities
|
$3,338,000.00 |
|
Equity
|
$2,600,000.00 |
|
Shares Out
|
5208915.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,364,000.00 |
| Market Analysis |
Market Cap
|
$3,750,418.80 |
|
Price
|
$0.75 |
|
BVPS
|
0.50 |
|
PB
|
1.44 |
|
EPS
|
-1.33 |
|
FCF
|
$-4,364,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FBLG documents filed with the SEC.
FBLG Filings
Clear
